Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Clin Oral Investig ; 22(1): 255-265, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-28357643

RESUMO

OBJECTIVES: Alendronate and raloxifene, a bisphosphonate and a selective estrogen modulator, respectively, are established osteoporosis therapies. Current evidence suggests that simultaneous application of osteoporosis therapies modulates osseointegration. However, alendronate shows inconsistent findings and raloxifene has not been studied comprehensively. This study aimed to evaluate the bone dynamics and molecular and microstructural features at the peri-implant bone interface in osteoporotic rats. MATERIALS AND METHODS: Thirty female rats underwent ovariectomy and were fed a diet low in calcium and phosphate and treated with alendronate or raloxifene for 30 days or underwent fictional ovariectomy surgery (SHAM) prior to implant insertion in the tibia; osteoporosis therapies continued thereafter. After 42 days, peri-implant bone was evaluated by histometric and micro-CT analysis. Fluorochrome incorporation and gene expression was determined to evaluate bone turnover. RESULTS: We report here that alendronate had no impact on bone-to-implant contacts and the mineral apposition rate. The RANKL/OPG ratio and local bone volume, however, were increased compared to the untreated osteoporotic rats. Even though signaling to bone resorption activity through RANKL production was observed in the alendronate group, the blockade of bone resorption activity that occurs in decorrence to alendronate activity took place and resulted in an increase in bone volume. Raloxifene significantly increased osseointegration in osteoporotic rats, as indicated by bone-to-implant contacts, mineral apposition, and local bone volume. Raloxifene, however, had no considerable impact on the RANKL/OPG ratio compared to untreated osteoporotic rats. As expected, the SH group showed higher bone-to-implant contacts and mineral apposition rates than the untreated osteoporotic rats. CONCLUSIONS: These findings suggest that raloxifene but not alendronate can compensate for the impaired osseointegration in osteoporotic rats. CLINICAL RELEVANCE: Regarding the superiority of raloxifene observed in the improvement of bone dynamics response, this statement suggests that raloxifene could be a good option for osteoporosis patients in oral rehabilitation procedures.


Assuntos
Alendronato/farmacologia , Implantes Dentários , Osseointegração/efeitos dos fármacos , Osteoporose/tratamento farmacológico , Cloridrato de Raloxifeno/farmacologia , Animais , Densidade Óssea/efeitos dos fármacos , Modelos Animais de Doenças , Feminino , Técnicas Imunoenzimáticas , Implantes Experimentais , Microscopia Confocal , Ovariectomia , Ratos , Ratos Wistar , Reação em Cadeia da Polimerase em Tempo Real , Tíbia/cirurgia , Microtomografia por Raio-X
2.
J Craniofac Surg ; 28(7): e679-e680, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28857990

RESUMO

The mandibular fractures in pediatric patients are rare, and they can need a fast and safe treatment. We present a case of a pediatric patient with "Andy Gump" fracture, resulting in a retrognathic mandible, distress to breathe, and functional discomfort to the patient caused by a cycling accident. The treatment was successful with the fast release of airway path and use of titanium plates to fix the fracture.


Assuntos
Fraturas Mandibulares , Retrognatismo , Criança , Feminino , Fixação Interna de Fraturas , Humanos
3.
Materials (Basel) ; 14(18)2021 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-34576463

RESUMO

(1) Background: Hypersensitivity reactions to metals may arise in predisposed patients chronically exposed to metallic materials, including dental implants made of titanium alloys. The purpose of this article was to systematically review titanium allergy manifestations in patients treated with dental implants and report a clinical case; (2) Methods: A systematic electronic search was performed for articles published in the English language until July 2021. The following eligibility criteria were adopted: (1) Population: individuals undergoing titanium and/or titanium alloy implant-supported rehabilitations; (2) Exposure: peri-implant soft tissue reactions attributable to implant insertion; (3) Outcome: evidence of titanium allergy, diagnostic methods, and forms of resolution; (3) Results: The included studies, in summary, presented evidence that titanium should not be considered an inert material, being able to trigger allergic reactions, and may be responsible for implant failure. A 55-year-old male patient received 3 implants in the posterior region of the left mandible and presented an epulis-like lesion developed from the peri-implant mucosa. The immunohistochemical analysis of the biopsy specimen confirmed the initial diagnosis of allergic reaction to titanium; (4) Conclusions: Although the evidence is weak, and titanium allergy has a low incidence, hypersensitivity reactions should not be underestimated. A rapid and conclusive diagnosis is mandatory to prevent further complications.

4.
Sci Rep ; 11(1): 24445, 2021 12 27.
Artigo em Inglês | MEDLINE | ID: mdl-34961782

RESUMO

The aim of this study is to evaluate the preemptive analgesic effects of dexamethasone (DEX) alone or combined with non-steroidal anti-inflammatory drugs (NSAIDs) in third molar surgeries. The subjects were divided into five groups (n = 20 teeth/group); subjects received only 8 mg of dexamethasone 1 h before the surgical procedure (DEX group), or in combination with etodolac (DEX + ETO), ketorolac (DEX + KET), ibuprofen (DEX + IBU), loxoprofen (DEX + LOX). Paracetamol 750 mg was provided as the number of rescue analgesics (NRA). Salivary PGE2 expression was measured preoperatively and at 48 h. Edema and Maximum mouth opening (MMO) were measured postoperatively at 48 h and 7 days. A visual analog scale (VAS) was performed postoperatively at 6, 12, 24, 48, 72 h, and 7 days. Salivary expression of PGE2 showed a decrease only for the DEX group. Edema and MMO and NRA consumption showed no significant differences among the groups (P > 0.05). The VAS showed a significantly lower pain perception at 6 h after the surgery for the DEX + ETO and DEX + KET groups (P < 0.05). The combination of DEX and NSAIDS should be considered for preemptive acute postsurgical pain management in third molar surgery. In some drug associations such as dexamethasone 8 mg + NSAIDS (ETO and KET) in the pre-operative time, only a few rescue analgesics are necessary.


Assuntos
Analgésicos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Dexametasona/uso terapêutico , Dente Serotino/cirurgia , Extração Dentária , Adolescente , Adulto , Quimioterapia Combinada , Etodolac/uso terapêutico , Feminino , Glucocorticoides/uso terapêutico , Humanos , Ibuprofeno/uso terapêutico , Cetorolaco/uso terapêutico , Masculino , Fenilpropionatos/uso terapêutico , Estudos Prospectivos , Extração Dentária/métodos , Adulto Jovem
5.
J Appl Oral Sci ; 26: e20160531, 2018 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-29340480

RESUMO

OBJECTIVE: The aim of this study was to evaluate the osteoconductive potential of BoneCeramic™ on bone healing in rat calvaria 5-mm defects. MATERIAL AND METHODS: A 5-mm calvaria bone defect was induced in three groups and the defect was not filled with biomaterial [Clot Group (CG)], autogenous bone (AG), or Bone Ceramic Group (BCG). Animals were euthanized after 14 or 28 days and the bone tissue within the central area of the bone defect was evaluated. Results were compared using ANOVA and Tukey test (p<0.05). Immunohistochemistry was performed using primary antibodies against osteocalcin, RUNX-2, TRAP, VEGF proteins, and 3-dimensional images of the defects in µCT were obtained to calculate bone mineral density (BMD). RESULTS: In BCG, the defect was completely filled with biomaterial and new bone formation, which was statistically superior to that in the GC group, at both time-points (p<0.001 for 14 days; p=0.002 for 28 days). TRAP protein showed weak, RUNX-2 showed a greater immunolabeling when compared with other groups, VEGF showed moderate immunostaining, while osteocalcin was present at all time-points analyzed. The µCT images showed filling defect by BCG (BMD= 1337 HU at 28 days). CONCLUSION: Therefore, the biomaterial tested was found to be favorable to fill bone defects for the reporting period analyzed.


Assuntos
Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos/farmacologia , Hidroxiapatitas/farmacologia , Crânio/efeitos dos fármacos , Cicatrização/efeitos dos fármacos , Animais , Densidade Óssea , Regeneração Óssea/fisiologia , Substitutos Ósseos/uso terapêutico , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Hidroxiapatitas/uso terapêutico , Imuno-Histoquímica , Masculino , Osteocalcina/análise , Ratos Wistar , Reprodutibilidade dos Testes , Crânio/patologia , Fosfatase Ácida Resistente a Tartarato/análise , Fatores de Tempo , Resultado do Tratamento , Fator A de Crescimento do Endotélio Vascular/análise , Cicatrização/fisiologia
6.
J Appl Oral Sci ; 26: e20170470, 2018 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-29995145

RESUMO

INTRODUCTION: The hypothesis of this study was that the peri-implant bone healing of the group of pinealectomized rats would differ from the control group. The samples were subjected to immunohistochemical, microtomographic (total porosity and connectivity density), and fluorochrome (mineralized surface) analyses. OBJECTIVES: The goal of this study was to investigate the cellular changes and bone remodeling dynamics along the bone/implant interface in pinealectomized rats. MATERIAL AND METHODS: The total of 18 adult male rats (Rattus norvegicus albinus, Wistar) was divided into three groups (n=6): control (CO), pinealectomized without melatonin (PNX) and pinealectomized with melatonin (PNXm). All animals were submitted to the first surgery (pinealectomy), except the CO group. Thirty days after the pinealectomy without melatonin, the second surgery was conducted, in which all animals received an implant in each tibia (36 titanium implants with surface treatment were installed - Implalife® São Paulo, SP, Brazil). By gavage, the rats of the PNX group received the vehicle solution, and the procedure. RESULTS: Immunohistochemical analysis for runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), osteopontin (OP) and osteocalcin (OC) showed that the bone repair process in the PNXm group was similar to that of the CO group, whereas the PNX group showed a delay. The microtomographic parameters of total porosity [Po(tot)] and bone surface (BS) showed no statistically significant differences, whereas for the connective density (Conn.Dn) a statistical difference was found between the CO and PNXm groups. Fluorochrome analysis of the active mineralized surface showed statistically significant difference between the CO and PNX and between the CO and PNXm groups. CONCLUSION: The absence of the pineal gland impaired the bone repair process during osseointegration, however the daily melatonin replacement was able to restore this response.


Assuntos
Conservadores da Densidade Óssea/farmacologia , Interface Osso-Implante , Melatonina/farmacologia , Osseointegração/efeitos dos fármacos , Glândula Pineal/cirurgia , Fosfatase Alcalina/análise , Animais , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Implantação Dentária Endóssea , Corantes Fluorescentes , Imuno-Histoquímica , Implantes Experimentais , Masculino , Osteocalcina/análise , Osteopontina/análise , Ratos Wistar , Reprodutibilidade dos Testes , Tíbia/efeitos dos fármacos , Tíbia/patologia , Tíbia/cirurgia , Titânio , Resultado do Tratamento , Microtomografia por Raio-X
7.
J Appl Oral Sci ; 25(1): 42-52, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28198975

RESUMO

OBJECTIVE: The aim of this study was to evaluate the bone repair process at the bone/implant interface of osteoporotic rats treated with sodium alendronate through the analysis of microtomography, real time polymerase chain reactions and immunohistochemistry (RUNX2 protein, bone sialoprotein (BSP), alkaline phosphatase, osteopontin and osteocalcin). MATERIAL AND METHODS: A total of 42 rats were used and divided in to the following experimental groups: CTL: control group (rats submitted to fictitious surgery and fed with a balanced diet), OST: osteoporosis group (rats submitted to a bilateral ovariectomy and fed with a low calcium diet) and ALE: alendronate group (rats submitted to a bilateral ovariectomy, fed with a low calcium diet and treated with sodium alendronate). A surface treated implant was installed in both tibial metaphyses of each rat. Euthanasia of the animals was conducted at 14 (immunhostochemistry) and 42 days (immunohistochemistry, micro CT and PCR). Data were subjected to statistical analysis with a 5% significance level. RESULTS: Bone volume (BV) and total pore volume were higher for ALE group (P<0.05). Molecular data for RUNX2 and BSP proteins were significantly expressed in the ALE group (P<0.05), in comparison with the other groups. ALP expression was higher in the CTL group (P<0.05). The immunostaining for RUNX2 and osteopontin was positive in the osteoblastic lineage cells of neoformed bone for the CTL and ALE groups in both periods (14 and 42 days). Alkaline phosphatase presented a lower staining area in the OST group compared to the CTL in both periods and the ALE at 42 days. CONCLUSION: There was a decrease of osteocalcin precipitation at 42 days for the ALE and OST groups. Therefore, treatment with short-term sodium alendronate improved bone repair around the implants installed in the tibia of osteoporotic rats.


Assuntos
Alendronato/farmacologia , Conservadores da Densidade Óssea/farmacologia , Implantes Dentários , Osseointegração/efeitos dos fármacos , Osteoporose/tratamento farmacológico , Fosfatase Alcalina/análise , Fosfatase Alcalina/efeitos dos fármacos , Animais , Densidade Óssea/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Subunidade alfa 1 de Fator de Ligação ao Core/efeitos dos fármacos , Implantação Dentária Endóssea , Feminino , Imuno-Histoquímica , Implantes Experimentais , Osteoblastos/efeitos dos fármacos , Osteocalcina/análise , Osteocalcina/efeitos dos fármacos , Osteopontina/análise , Osteopontina/efeitos dos fármacos , Osteoporose/fisiopatologia , Ovariectomia , Ratos Wistar , Reação em Cadeia da Polimerase em Tempo Real , Reprodutibilidade dos Testes , Tíbia/cirurgia , Fatores de Tempo , Microtomografia por Raio-X
8.
J Lasers Med Sci ; 8(4): 201-203, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29071028

RESUMO

Case Presentation: This study aimed to report a case of medication related osteonecrosis of the jaw (MRONJ) of a 65-year-old female patient referred to the Oral and Maxillofacial Surgery team from Araçatuba Dental School, complaining about mobility of a previously dental implant placed on the posterior maxillary region. Clinical examination revealed an extensive necrosis area around the implant region. The patient reported bisphosphonate therapy with sodium alendronate for prevention of osteoporosis 5 years ago. A diagnosis of MRONJ was reached and the treatment decided was to remove the dental implant damaged and use the lower-level laser therapy (LLLT) associated with antibiotic therapy with clindamycin 300 mg and mouth rinses with chlorhexidine 0.12%. Conclusion: Six months after the treatment with LLLT a complete healing of the affected area was observed and 12 months after treatment the patient was rehabilitated with fixed dental prosthesis and showed excellent tissue healing of the necrosis areas. It was concluded that the use of LLLT showed to be a good option in the treatment of MRONJ.

10.
Oral Maxillofac Surg ; 18(3): 305-10, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23620250

RESUMO

Procedures for the surgical correction of dentofacial deformities may produce important complications, whether due to the potential for vascular injury or to prolonged surgery, both of which may lead to severe blood loss. Fluid replacement with crystalloid, colloid, or even blood products may be required. The aim of this study was to assess blood loss and transfusion requirements in 45 patients (18 males and 27 females; mean age 29.29 years, range 16-52 years) undergoing orthognathic surgery, assigned to one of two groups according to procedure type-rapid maxillary expansion or double-jaw orthognathic surgery. Preoperative hemoglobin and hematocrit levels and intraoperative blood loss were measured. There was a substantial individual variation in pre- and postoperative hemoglobin values (10.3-17 and 8.8-15.4 g/dL, respectively; p < 0.05). Mean hematocrit values were 41.53 % preoperatively (range 31.3-50.0 %) and 36.56 % postoperatively (range 25-43.8 %) (p < 0.05). Mean blood loss was 274.60 mL (range 45-855 mL). Only two patients required blood transfusion. Although blood loss and transfusion requirements were minimal in the present study, surgical teams should monitor the duration of surgery and follow meticulous protocols to minimize the risks.


Assuntos
Perda Sanguínea Cirúrgica , Transfusão de Sangue , Procedimentos Cirúrgicos Ortognáticos/métodos , Adolescente , Adulto , Anestesia Geral/métodos , Perda Sanguínea Cirúrgica/prevenção & controle , Pressão Sanguínea/fisiologia , Feminino , Hematócrito , Hemoglobinas/análise , Humanos , Masculino , Osteotomia Mandibular/métodos , Maxila/cirurgia , Osteotomia Maxilar/métodos , Pessoa de Meia-Idade , Monitorização Intraoperatória , Duração da Cirurgia , Técnica de Expansão Palatina , Adulto Jovem
11.
J. appl. oral sci ; 26: e20160531, 2018. graf
Artigo em Inglês | LILACS, BBO - odontologia (Brasil) | ID: biblio-893737

RESUMO

Abstract Objective: The aim of this study was to evaluate the osteoconductive potential of BoneCeramic™ on bone healing in rat calvaria 5-mm defects. Material and Methods: A 5-mm calvaria bone defect was induced in three groups and the defect was not filled with biomaterial [Clot Group (CG)], autogenous bone (AG), or Bone Ceramic Group (BCG). Animals were euthanized after 14 or 28 days and the bone tissue within the central area of the bone defect was evaluated. Results were compared using ANOVA and Tukey test (p<0.05). Immunohistochemistry was performed using primary antibodies against osteocalcin, RUNX-2, TRAP, VEGF proteins, and 3-dimensional images of the defects in μCT were obtained to calculate bone mineral density (BMD). Results: In BCG, the defect was completely filled with biomaterial and new bone formation, which was statistically superior to that in the GC group, at both time-points (p<0.001 for 14 days; p=0.002 for 28 days). TRAP protein showed weak, RUNX-2 showed a greater immunolabeling when compared with other groups, VEGF showed moderate immunostaining, while osteocalcin was present at all time-points analyzed. The μCT images showed filling defect by BCG (BMD= 1337 HU at 28 days). Conclusion: Therefore, the biomaterial tested was found to be favorable to fill bone defects for the reporting period analyzed.


Assuntos
Animais , Masculino , Crânio/efeitos dos fármacos , Cicatrização/efeitos dos fármacos , Regeneração Óssea/efeitos dos fármacos , Substitutos Ósseos/farmacologia , Hidroxiapatitas/farmacologia , Crânio , Crânio/patologia , Fatores de Tempo , Cicatrização/fisiologia , Regeneração Óssea/fisiologia , Imuno-Histoquímica , Densidade Óssea , Osteocalcina/análise , Resultado do Tratamento , Ratos Wistar , Substitutos Ósseos/uso terapêutico , Fator A de Crescimento do Endotélio Vascular/análise , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Fosfatase Ácida Resistente a Tartarato/análise , Hidroxiapatitas/uso terapêutico
12.
Arch. health invest ; 7(11): 477-481, nov. 2018.
Artigo em Português | BBO - odontologia (Brasil) | ID: biblio-994783

RESUMO

Introdução: Os implantes curtos têm ganhado espaço na implantodontia moderna devido se tratar de uma técnica que apresenta baixa morbidade, sem necessidade de cirurgias de enxertos prévias e menor custo para o paciente, quando comparada a outras técnicas. Objetivo: Dessa forma, foi realizada uma revisão da literatura atual sobre as vantagens e indicações desta técnica comparando-a as técnicas convencionais. Materiais e métodos: A pesquisa bibliográfica foi realizada usando MEDLINE via PubMed, utilizando termos e outros termos livres dos Cabeçalhos de Assunto Médicos (MeSH) para pesquisar. Abrangendo artigos publicados em inglês, dos ultimos 18 anos. Resultados: Foram selecionados 56 referências, das quais 26 foram consideradas inadequadas. Resultando no total de 30 artigos considerados adequados aos critérios de seleção. Os artigos selecionados apresentaram em alguns pontos divergência que ainda necessitam de respostas baseadas em evidencias. Conclusão: Conclui-se com esta revisão que os implantes curtos são uma boa alternativa quando não se tem altura óssea suficiente para instalação de implantes convencionais, e que apresenta vantagens e indicações restritas no universo da implantodontia com resultados similares quando comparados aos implantes de tamanhos convencionais. Porém, apresentam resultados a curto prazo o que sugere a realização de estudos com longo tempo de acompanhamento que busquem responder sobre a qualidade da técnica nos diversos desafios encontrados na implantodontia(AU)


Introduction: The short implants have an open space in modern implantology due to a technique that presents low morbidity, without previous grafting surgeries and lower cost for the patient, when compared to other techniques. Objective: Thus, a review of current literature on the advantages and indications of technique was carried out comparing conventional techniques. Materials and methods: Bibliographic research was conducted using MEDLINE via PubMed, using terms and other free Medical Subject Headings (MeSH) terms to search for. Covering articles published in English, from the last 18 years. Results: We selected 56 references, of which 26 were considered inadequate. Resulting in a total of 30 articles considered adequate to the selection criteria. The selected articles presented in some points divergence that still need evidence based answers. Conclusion: It was concluded with this review that short implants are a good alternative when there is not enough height for the installation of conventional implants, and that they have advantages and restricted indications no universe of the implantology with similar results when compared to the implants of conventional sizes. However, results of a short term and that suggests a course of studies with a time of accompaniment that seek answers on a quality of the technique in the diverse challenges found in the implantology(AU)


Introducción: Los implantes cortos han ganado espacio en la implantodoncia moderna debido a que se trata de una técnica que presenta baja morbilidad, sin necesidad de cirugías de injertos previos y menor costo para el paciente, en comparación con otras técnicas. Objetivo: De esta forma, se realizó una revisión de la literatura actual sobre las ventajas e indicaciones de esta técnica comparándola con las técnicas convencionales. Materiales y métodos: La investigación bibliográfica fue realizada usando MEDLINE vía PubMed, utilizando términos y otros términos libres de los Cabeceros de Asunto Médicos (MeSH) para investigar. Abriendo artículos publicados en inglés, de los últimos 18 años. Resultados: Se seleccionaron 56 referencias, de las cuales 26 fueron consideradas inadecuadas. Resultando en el total de 30 artículos considerados adecuados a los criterios de selección. Los artículos seleccionados presentaron en algunos puntos divergencia que aún necesitan respuestas basadas en evidencias. Conclusión: Se concluye con esta revisión que los implantes cortos son una buena alternativa cuando no se tiene suficiente altura ósea para instalación de implantes convencionales y que presenta ventajas e indicaciones restringidas en el universo de la implantodoncia con resultados similares en comparación con los implantes de tamaños convencionales. Sin embargo, presentan resultados a corto plazo lo que sugiere la realización de estudios con largo tiempo de acompañamiento que busquen responder sobre la calidad de la técnica en los diversos desafíos encontrados en la implantodoncia(AU)


Assuntos
Reabsorção Óssea , Implantes Dentários , Reabilitação Bucal
13.
J. appl. oral sci ; 26: e20170329, 2018. graf
Artigo em Inglês | LILACS, BBO - odontologia (Brasil) | ID: biblio-893695

RESUMO

Abstract Raloxifene is an antiresorptive drug, selective estrogen receptor modulator (SERM) used in the treatment of osteoporosis. Objective To evaluate proteins related to bone repair at the peri-implant bone in a rat model of osteoporosis treated with raloxifene. Material and Methods 72 rats were divided into three groups: SHAM (healthy animals), OVX (ovariectomized animals), and RLX (ovariectomized animals treated with raloxifene). Raloxifene was administered by gavage (1 mg/kg/day). Tibial implantation was performed 30 days after ovariectomy, and animals were euthanized at 14, 42, and 60 days postoperatively. Samples were collected and analyzed by immunohistochemical reactions, molecular analysis, and microtomographic parameters. Results RLX showed intense staining of all investigated proteins at both time points except for RUNX2. These results were similar to SHAM and opposite to OVX, showing mild staining. The PCR gene expression of OC and ALP values for RLX (P<0.05) followed by SHAM and OVX groups. For BSP data, the highest expression was observed in the RLX groups and the lowest expression was observed in the OVX groups (P<0.05). For RUNX2 data, RLX and SHAM groups showed greater values compared to OVX (P<0.05). At 60 days postoperatively, microtomography parameters, related to closed porosity, showed higher values for (Po.N), (Po.V), and (Po) in RLX and SHAM groups, whereas OVX groups showed lower results (P<0.05); (BV) values (P=0.009); regarding total porosity (Po.tot), RLX group had statistically significant lower values than OVX and SHAM groups (P=0.009). Regarding the open porosity (Po.V and Po), the SHAM group presented the highest values, followed by OVX and RLX groups (P<0.05). The Structural Model Index (SMI), RLX group showed a value closer to zero than SHAM group (P<0.05). Conclusions Raloxifene had a positive effect on the expression of osteoblastogenesis/mineralization-related proteins and on micro-CT parameters related to peri-implant bone healing.


Assuntos
Animais , Feminino , Osteoblastos/efeitos dos fármacos , Osteogênese/efeitos dos fármacos , Osteoporose/tratamento farmacológico , Proteínas/análise , Proteínas/efeitos dos fármacos , Cloridrato de Raloxifeno/farmacologia , Moduladores Seletivos de Receptor Estrogênico/farmacologia , Osteoporose/patologia , Valores de Referência , Fatores de Tempo , Imuno-Histoquímica , Ovariectomia , Expressão Gênica , Osteocalcina/análise , Osteocalcina/efeitos dos fármacos , Reação em Cadeia da Polimerase , Reprodutibilidade dos Testes , Resultado do Tratamento , Ratos Wistar , Modelos Animais de Doenças , Proteínas Wnt/análise , Proteínas Wnt/efeitos dos fármacos , beta Catenina/análise , beta Catenina/efeitos dos fármacos , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Subunidade alfa 1 de Fator de Ligação ao Core/efeitos dos fármacos , Osteopontina/análise , Osteopontina/efeitos dos fármacos , Microtomografia por Raio-X
14.
J. appl. oral sci ; 26: e20170470, 2018. graf
Artigo em Inglês | LILACS, BBO - odontologia (Brasil) | ID: biblio-954503

RESUMO

Abstract The hypothesis of this study was that the peri-implant bone healing of the group of pinealectomized rats would differ from the control group. The samples were subjected to immunohistochemical, microtomographic (total porosity and connectivity density), and fluorochrome (mineralized surface) analyses. Objectives The goal of this study was to investigate the cellular changes and bone remodeling dynamics along the bone/implant interface in pinealectomized rats. Material and Methods The total of 18 adult male rats (Rattus norvegicus albinus, Wistar) was divided into three groups (n=6): control (CO), pinealectomized without melatonin (PNX) and pinealectomized with melatonin (PNXm). All animals were submitted to the first surgery (pinealectomy), except the CO group. Thirty days after the pinealectomy without melatonin, the second surgery was conducted, in which all animals received an implant in each tibia (36 titanium implants with surface treatment were installed - Implalife® São Paulo, SP, Brazil). By gavage, the rats of the PNX group received the vehicle solution, and the procedure. Results Immunohistochemical analysis for runt-related transcription factor 2 (RUNX2), alkaline phosphatase (ALP), osteopontin (OP) and osteocalcin (OC) showed that the bone repair process in the PNXm group was similar to that of the CO group, whereas the PNX group showed a delay. The microtomographic parameters of total porosity [Po(tot)] and bone surface (BS) showed no statistically significant differences, whereas for the connective density (Conn.Dn) a statistical difference was found between the CO and PNXm groups. Fluorochrome analysis of the active mineralized surface showed statistically significant difference between the CO and PNX and between the CO and PNXm groups. Conclusion The absence of the pineal gland impaired the bone repair process during osseointegration, however the daily melatonin replacement was able to restore this response.


Assuntos
Animais , Masculino , Glândula Pineal/cirurgia , Osseointegração/efeitos dos fármacos , Conservadores da Densidade Óssea/farmacologia , Interface Osso-Implante , Melatonina/farmacologia , Tíbia/efeitos dos fármacos , Tíbia/lesões , Tíbia/patologia , Titânio , Imuno-Histoquímica , Osteocalcina/análise , Reprodutibilidade dos Testes , Resultado do Tratamento , Ratos Wistar , Implantes Experimentais , Implantação Dentária Endóssea , Fosfatase Alcalina/análise , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Osteopontina/análise , Microtomografia por Raio-X , Corantes Fluorescentes
15.
J. appl. oral sci ; 25(1): 42-52, Jan.-Feb. 2017. graf
Artigo em Inglês | LILACS, BBO - odontologia (Brasil) | ID: biblio-841161

RESUMO

Abstract Sodium alendronate is a bisphosphonate drug that exerts antiresorptive action and is used to treat osteoporosis. Objective The aim of this study was to evaluate the bone repair process at the bone/implant interface of osteoporotic rats treated with sodium alendronate through the analysis of microtomography, real time polymerase chain reactions and immunohistochemistry (RUNX2 protein, bone sialoprotein (BSP), alkaline phosphatase, osteopontin and osteocalcin). Material and Methods A total of 42 rats were used and divided in to the following experimental groups: CTL: control group (rats submitted to fictitious surgery and fed with a balanced diet), OST: osteoporosis group (rats submitted to a bilateral ovariectomy and fed with a low calcium diet) and ALE: alendronate group (rats submitted to a bilateral ovariectomy, fed with a low calcium diet and treated with sodium alendronate). A surface treated implant was installed in both tibial metaphyses of each rat. Euthanasia of the animals was conducted at 14 (immunhostochemistry) and 42 days (immunohistochemistry, micro CT and PCR). Data were subjected to statistical analysis with a 5% significance level. Results Bone volume (BV) and total pore volume were higher for ALE group (P<0.05). Molecular data for RUNX2 and BSP proteins were significantly expressed in the ALE group (P<0.05), in comparison with the other groups. ALP expression was higher in the CTL group (P<0.05). The immunostaining for RUNX2 and osteopontin was positive in the osteoblastic lineage cells of neoformed bone for the CTL and ALE groups in both periods (14 and 42 days). Alkaline phosphatase presented a lower staining area in the OST group compared to the CTL in both periods and the ALE at 42 days. Conclusion There was a decrease of osteocalcin precipitation at 42 days for the ALE and OST groups. Therefore, treatment with short-term sodium alendronate improved bone repair around the implants installed in the tibia of osteoporotic rats.


Assuntos
Animais , Feminino , Osteoporose/tratamento farmacológico , Implantes Dentários , Osseointegração/efeitos dos fármacos , Alendronato/farmacologia , Conservadores da Densidade Óssea/farmacologia , Osteoblastos/efeitos dos fármacos , Osteoporose/fisiopatologia , Tíbia/cirurgia , Fatores de Tempo , Imuno-Histoquímica , Ovariectomia , Densidade Óssea/efeitos dos fármacos , Osteocalcina/análise , Osteocalcina/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Reprodutibilidade dos Testes , Ratos Wistar , Implantes Experimentais , Implantação Dentária Endóssea , Fosfatase Alcalina/análise , Fosfatase Alcalina/efeitos dos fármacos , Subunidade alfa 1 de Fator de Ligação ao Core/análise , Subunidade alfa 1 de Fator de Ligação ao Core/efeitos dos fármacos , Osteopontina/análise , Osteopontina/efeitos dos fármacos , Microtomografia por Raio-X , Reação em Cadeia da Polimerase em Tempo Real
16.
Araçatuba; s.n; 2019. 64 p. ilus, tab, graf.
Tese em Português | LILACS, BBO - odontologia (Brasil) | ID: biblio-1051336

RESUMO

Este trabalho teve como objetivo avaliar o efeito da biomodulação e bioatividade no reparo ósseo de ratas ovariectomizadas submetidas à simulação de fraturas femurais. Sessenta e quatro ratas Wistar (Rattus novergicus), fêmeas, com 6 meses de idade, em que metade dos animais foram submetidos à ovariectomia bilateral (OVX) e a outra metade à cirurgia fictícia de ovariectomia (SHAM), e um período de 3 meses foi acompanhado para a verificar se a osteoporose estava presente. As ratas foram submetidas à simulação de fratura em ambos os fêmures e a fratura foi fixada com miniplaca e parafusos do sistema 1,5 mm. A metade das amostrastiveram miniplacas com texturização de superfície tratadas por oxidação com plasma eletrolítico (PEO), que ficou em contato com o "gap" reparacional e, a outra metade com miniplacas convencionais, com superfície (CONV). Estes grupos experimentais não foram submetidos à biomodulação (CO). Para o mesmo desenho experimental dos grupos, no ato operatório, após a fixação das fraturas, os demais grupos experimentais foram submetidos à fotobiomodulação por meio da irradiação do laser de baixa intensidade (LASER), durante 5 minutos. Aos 14 e 42 dias de pós-operatório, foi administrada calceína e alizarina, respectivamente, pela via intramuscular, na dose de 20 mg/kg de peso. A eutanásia de todos os animais foi realizada aos 60 dias de pós-operatório. Os grupos experimentais (SHAM/LASER/CONV; SHAM/CO/CONV; SHAM/LASER/PEO; SHAM/CO/PEO; OVX/LASER/CONV; OVX/CO/CONV; OVX/LASER/PEO; OVX/CO/PEO), após a eutanásia, tiveram as regiões de interesse, inicialmente escaneadas em microtomografia computadorizada para avaliação dos parâmetros volumétricos do osso (BV/TV) e qualidade óssea PO(tot) (Tb.Th, Tb.Sp e Tb.N), em seguida as peças continuaram em processamento para inclusão em resina fotopolimerizável. As lâminas foram escaneadas em microscopia confocal a laser para análise da área em pixels2 de precipitação mineral óssea (APMO). Após este processo, as lâminas foram coradas em vermelho de alizarina e azul de Stevenel para histometria de área de osso neoformado (NBF) no "gap" reparacional e análise do padrão reparacional. Os resultados foram inferiores e estatisticamente significantes (p< 0,05) na análise de MicroCT na comparação do grupo OVX/CO/CONV com os demais grupos nos parâmetros (BV.TV, Tb.N e Tb.Th); APMO apresentou menor área para o fluorocromo vermelho de alizarina nos grupos OVX/CO/CONV e OVX/CO/PEO (p<0,05). No grupo OVX, o laser mostrou maior turnover ósseo (p< 0,05) para NBF e pior padrão histológico. Conclusão: A fotobiomodulação e bioatividade otimizaram o reparo ósseo de fraturas em fêmures de ratas ovariectomizadas(AU)


The aim of this study was to evaluate the effect of biomodulation and bioactivity on the bone repair of ovariectomized rats submitted to simulation of femoral fractures. 64 female adults Wistar rats (Rattus novergicus), which half of the animals was submitted to bilateral ovariectomy (OVX) and the other half to the dummy ovariectomy surgery (SHAM), and after 3-month the osteoporosis was induced. The rats were submitted to fracture simulation in both of the femurs and the fracture was fixed with miniplate and screws of the system 1.5 mm. Half of the samples had surface-textured miniplatestreated by with plasma electrolytic oxidation (PEO), which was in contact with the repair gap, and the other half with conventional miniplates with surface (CONV). These experimental groups were not submitted to biomodulation (CO). For the same experimental design of the groups, after fracture fixation, the other experimental groups were submitted to photobiomodulation through low level laser (laser), for 5 minutes. At 14 and 42 postoperative days, calcein and alizarin, respectively, were administered intramuscularly at a dose of 20 mg / kg body weight. The animals were euthanized at 60 postoperative days. The experimental groups (SHAM/LASER/CONV, SHAM/CO/CONV, SHAM/LASER/PEO, SHAM/CO/PEO, OVX/LASER/CONV, OVX/CO/CONV, OVX/LASER/PEO), after euthanasia, had the regions of interest, initially scanned in computerized microtomography to evaluate the bone volume parameters [BV / TV] and bone quality PO (tot) and (Tb.Th, Tb.Sp and Tb.N), then the samples were processed for inclusion in photopolymerizable resin.. The slides were scanned in confocal laser microscopy for analysis of the area in pixels2 of bone mineral precipitation (APMO). After this process, the slides were stained in alizarin red and Stevenel blue for neoformed bone area (NBF) in the reparative gap and analysis of the histology pattern. The results showed lower and statistically significant results (p <0.05) for MicroCT parameters (BV.TV, Tb.N and Tb.Th) in the comparison between OVX / CO / CONV and the other groups; APMO showed lower area for the alizarin red fluorochrome in the OVX / CO / CONV and OVX / CO / PEO groups (p <0.05). In the OVX, the laser showed greater bone turnover (P<0,05); The OVX / CO / CONV showed lower NBF (p <0.05) and worse histological pattern. Conclusion: The photobiomodulation and bioactivity optimized the bone repair of femur fractures in ovariectomized rats(AU)


Assuntos
Animais , Ratos , Osteoporose , Regeneração Óssea , Ovariectomia , Ratos Wistar , Fixação de Fratura , Fixação Interna de Fraturas
18.
Araçatuba; s.n; 2016. 62 p. ilus, tab, graf.
Tese em Português | LILACS, BBO - odontologia (Brasil) | ID: biblio-870103

RESUMO

O presente estudo teve como objetivo investigar a interface osso / implante em ratos pinealectomizados tratados com melatonina. Métodos: 30 ratos, machos, adultos foram divididos em 3 grupos: controle (CO), pinealectomizados (PnX) e pinealectomizado com melatonina (PNXm). Após 30 dias da Pinealectomia, um implante foi instalado em cada tíbia e a eutanásia foi realizada aos 42 dias. As amostras foram submetidas a histomorfométrica (ELCOI e AON), biomecânica (de torque reverso), microtomografia e análise imunoistoquímica. Os dados quantitativos foram submetidos à análise estatística (P <0,05). Para os resultados histométricos, valores ELCOI para PNX foram menores quando comparados com PNXm (P = 0,0393), enquanto AON não mostrou diferença entre os grupos (P = 0,761). Os valores de torque reverso não mostraram diferença entre os grupos PNX e PNXm (P = 0,5000), e as interações CO vs PNXm, e CO vs PNX mostraram diferença significativa (P <0,05). Os parâmetros volumétricas BV/TV (P = 0,933); Tr.N (P = 0,933); Tb.Th (P = 0,933), Tb.Sp (P = 0,200) não apresentaram diferença estatística. A imunomarcação para OPG, RANKL, TRAP e osteocalcina mostrou similaridade entre os grupos, apesar da PNXm parece assemelhar-se às condições fisiológicas (CO). Portanto, a melatonina melhorou a remodelação óssea na região peri-implante em ratos pinealectomizados.


This study aimed to investigate the interface bone/implant in pinealectomized rats treated with melatonin. 30 rats, male, adults were divided into 3 groups: control (CO), pinealectomized (PNX) and pinealectomized with melatonin (PNXm). After 30 days of the pinealectomy, one implant was installed on each tibia and euthanasia was performed at 42 days. The samples were submitted to histometric (BIC and NB), biomechanical (reverse torque), microtomography and immunohistochemical analysis. The quantitative data were subjected to statistical analysis (P<0.05). For the histometric results, BIC values to PNX were lower when compared to PNXm (P=0.0393), whereas NB did not showed difference among the groups (P=0.761). Reverse torque did not show difference between the groups PNX and PNXm (P=0,5000), and the interactions CO vs PNXm, and CO vs PNX showed significantly difference (P<0.05). The volumetric parameters BV/TV (P=0.933); Tr.N (P=0.933); Tb.Th (P=0.933), Tb.Sp (P=0.200) did not present statistical difference. The immunolabeling for OPG, RANKL, TRAP and osteocalcin showed similarity among the groups, despite the PNXm it seems to resemble to physiological conditions (CO). Therefore, melatonin improved the bone turnover in peri-implant region in pinealectomized rats.


Assuntos
Animais , Ratos , Transtornos Cronobiológicos , Implantes Dentários , Melatonina , Glândula Pineal , Transtornos do Sono do Ritmo Circadiano , Ratos Wistar , Tíbia
19.
Araçatuba; s.n; 2016. 62 p. ilus, tab, graf.
Tese em Português | BBO - odontologia (Brasil) | ID: biblio-867481

RESUMO

O presente estudo teve como objetivo investigar a interface osso / implante em ratos pinealectomizados tratados com melatonina. Métodos: 30 ratos, machos, adultos foram divididos em 3 grupos: controle (CO), pinealectomizados (PnX) e pinealectomizado com melatonina (PNXm). Após 30 dias da Pinealectomia, um implante foi instalado em cada tíbia e a eutanásia foi realizada aos 42 dias. As amostras foram submetidas a histomorfométrica (ELCOI e AON), biomecânica (de torque reverso), microtomografia e análise imunoistoquímica. Os dados quantitativos foram submetidos à análise estatística (P <0,05). Para os resultados histométricos, valores ELCOI para PNX foram menores quando comparados com PNXm (P = 0,0393), enquanto AON não mostrou diferença entre os grupos (P = 0,761). Os valores de torque reverso não mostraram diferença entre os grupos PNX e PNXm (P = 0,5000), e as interações CO vs PNXm, e CO vs PNX mostraram diferença significativa (P <0,05). Os parâmetros volumétricas BV/TV (P = 0,933); Tr.N (P = 0,933); Tb.Th (P = 0,933), Tb.Sp (P = 0,200) não apresentaram diferença estatística. A imunomarcação para OPG, RANKL, TRAP e osteocalcina mostrou similaridade entre os grupos, apesar da PNXm parece assemelhar-se às condições fisiológicas (CO). Portanto, a melatonina melhorou a remodelação óssea na região peri-implante em ratos pinealectomizados


This study aimed to investigate the interface bone/implant in pinealectomized rats treated with melatonin. 30 rats, male, adults were divided into 3 groups: control (CO), pinealectomized (PNX) and pinealectomized with melatonin (PNXm). After 30 days of the pinealectomy, one implant was installed on each tibia and euthanasia was performed at 42 days. The samples were submitted to histometric (BIC and NB), biomechanical (reverse torque), microtomography and immunohistochemical analysis. The quantitative data were subjected to statistical analysis (P<0.05). For the histometric results, BIC values to PNX were lower when compared to PNXm (P=0.0393), whereas NB did not showed difference among the groups (P=0.761). Reverse torque did not show difference between the groups PNX and PNXm (P=0,5000), and the interactions CO vs PNXm, and CO vs PNX showed significantly difference (P<0.05). The volumetric parameters BV/TV (P=0.933); Tr.N (P=0.933); Tb.Th (P=0.933), Tb.Sp (P=0.200) did not present statistical difference. The immunolabeling for OPG, RANKL, TRAP and osteocalcin showed similarity among the groups, despite the PNXm it seems to resemble to physiological conditions (CO). Therefore, melatonin improved the bone turnover in peri-implant region in pinealectomized rats


Assuntos
Animais , Ratos , Transtornos Cronobiológicos , Implantes Dentários , Melatonina , Glândula Pineal , Transtornos do Sono do Ritmo Circadiano , Ratos Wistar , Tíbia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA